S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Avoid the upcoming bloodbath (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
Avoid the upcoming bloodbath (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
Nigeria's central bank chief arrested after being suspended by president
Avoid the upcoming bloodbath (Ad)
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Avoid the upcoming bloodbath (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
Avoid the upcoming bloodbath (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
Nigeria's central bank chief arrested after being suspended by president
Avoid the upcoming bloodbath (Ad)
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Avoid the upcoming bloodbath (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
Avoid the upcoming bloodbath (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
Nigeria's central bank chief arrested after being suspended by president
Avoid the upcoming bloodbath (Ad)
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Avoid the upcoming bloodbath (Ad)
How major US stock indexes fared Friday 6/9/2023
FuelCell Is Back To Realistic Valuation
Avoid the upcoming bloodbath (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
Nigeria's central bank chief arrested after being suspended by president
Avoid the upcoming bloodbath (Ad)
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive

U.S. Physical Therapy (USPH) Stock Forecast, Price & News

$110.12
+0.56 (+0.51%)
(As of 06/9/2023 ET)
Compare
Today's Range
$107.49
$110.20
50-Day Range
$96.51
$114.29
52-Week Range
$73.30
$131.50
Volume
74,424 shs
Average Volume
204,309 shs
Market Capitalization
$1.44 billion
P/E Ratio
50.98
Dividend Yield
1.56%
Price Target
$116.00

U.S. Physical Therapy MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.3% Upside
$116.00 Price Target
Short Interest
Bearish
6.17% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.64mentions of U.S. Physical Therapy in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$45,122 Sold Last Quarter
Proj. Earnings Growth
19.77%
From $2.63 to $3.15 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

Medical Sector

398th out of 987 stocks

Health Services Industry

7th out of 13 stocks


USPH stock logo

About U.S. Physical Therapy (NYSE:USPH) Stock

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the following segments: physical therapy operations and industrial injury prevention services. The physical therapy operations segment consist of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The injury prevention services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. U.S. The company was founded in 1990 and is headquartered in Houston, TX.

Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

USPH Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
What to Know About Physical Therapy
See More Headlines

USPH Price History

USPH Company Calendar

Ex-Dividend for 4/7 Dividend
3/09/2023
Dividend Payable
4/07/2023
Last Earnings
5/03/2023
Ex-Dividend for 6/9 Dividend
5/17/2023
Dividend Payable
6/09/2023
Today
6/10/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
90337L10
Employees
6,135
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$116.00
High Stock Price Forecast
$116.00
Low Stock Price Forecast
$116.00
Forecasted Upside/Downside
+5.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$32.16 million
Pretax Margin
9.56%

Debt

Sales & Book Value

Annual Sales
$553.14 million
Cash Flow
$4.55 per share
Book Value
$24.39 per share

Miscellaneous

Free Float
12,828,000
Market Cap
$1.44 billion
Optionable
Optionable
Beta
1.35

Key Executives

  • Christopher J. ReadingChristopher J. Reading
    President, Chief Executive Officer & Director
  • Eric Joseph Williams
    Chief Operating Officer
  • Carey P. Hendrickson
    Chief Financial & Accounting Officer
  • Chadd Pence
    Vice President-Information Systems
  • Jayne Fleck Pool
    Chief Compliance Officer & VP-Clinical Services













USPH Stock - Frequently Asked Questions

Should I buy or sell U.S. Physical Therapy stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" USPH shares.
View USPH analyst ratings
or view top-rated stocks.

What is U.S. Physical Therapy's stock price forecast for 2023?

1 Wall Street analysts have issued 1-year price objectives for U.S. Physical Therapy's stock. Their USPH share price forecasts range from $116.00 to $116.00. On average, they predict the company's stock price to reach $116.00 in the next twelve months. This suggests a possible upside of 5.3% from the stock's current price.
View analysts price targets for USPH
or view top-rated stocks among Wall Street analysts.

How have USPH shares performed in 2023?

U.S. Physical Therapy's stock was trading at $81.03 on January 1st, 2023. Since then, USPH shares have increased by 35.9% and is now trading at $110.12.
View the best growth stocks for 2023 here
.

When is U.S. Physical Therapy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our USPH earnings forecast
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings data on Wednesday, May, 3rd. The company reported $0.59 earnings per share for the quarter, topping analysts' consensus estimates of $0.52 by $0.07. The company had revenue of $148.51 million for the quarter, compared to the consensus estimate of $140.77 million. U.S. Physical Therapy had a net margin of 5.40% and a trailing twelve-month return on equity of 10.93%. The company's revenue was up 12.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.65 EPS.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Wednesday, May 3rd. Shareholders of record on Thursday, May 18th will be paid a dividend of $0.43 per share on Friday, June 9th. This represents a $1.72 annualized dividend and a dividend yield of 1.56%. The ex-dividend date is Wednesday, May 17th.
Read our dividend analysis for USPH
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.72 per share and currently has a dividend yield of 1.57%. The company has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 79.63%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, USPH will have a dividend payout ratio of 54.60% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.43%), Kayne Anderson Rudnick Investment Management LLC (11.45%), Copeland Capital Management LLC (5.31%), Boston Trust Walden Corp (4.20%), State Street Corp (3.64%) and Riverbridge Partners LLC (3.13%). Insiders that own company stock include Anne Motsenbocker, Bernard A Harris Jr, Bernard A Harris, Jr, Carey P Hendrickson, Christopher J Reading, Christopher J Reading, Clayton Trier, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Richard Binstein.
View institutional ownership trends
.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $110.12.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy (NYSE:USPH) has a market capitalization of $1.44 billion and generates $553.14 million in revenue each year. The company earns $32.16 million in net income (profit) each year or $2.16 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

The company employs 6,135 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The official website for the company is www.usph.com. The company can be reached via phone at (713) 297-7000, via email at lmcafee@usph.com, or via fax at 713-297-7090.

This page (NYSE:USPH) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -